Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

First stem cell-based veterinary medicine approved
“A quarter of the entire equine population develops osteoarthritis at some point in their life."
Arti-Cell Forte for equine lameness available from May 2019 

The first stem cell-based veterinary medicine, used for treating equine lameness, will be available from May and June 2019.

Boehringer Ingelheim has launched Arti-Cell Forte in Europe for the ‘reduction of mild to moderate recurrent lameness associated with non-septic joint inflammation in horses’.

Described as a ‘groundbreaking first-ever approved treatment’, the drug targets lameness by utilising specifically primed, chondrogenic induced stem cells. It comes in an ultra-low frozen and ready-to-use format.

Boehringer said current treatments for lameness are not satisfactory for all cases and ‘there is a clear need for innovation and new treatment options’, looking at the underlying cause rather than just treating symptoms.

The company formed a partnership with Global Stem Cell Technology (GST) last year to develop new treatments and solutions to improve animal health.

Jan Spaas, CEO of GST, said: “A quarter of the entire equine population develops osteoarthritis at some point in their life. Priming the cells towards cartilage aids them to deliver the right activities in the affected joint.

“We are absolutely delighted with our first marketing authorisation from the European Commission and the first stem cell-based product in animal health. We are sure that with our partner Boehringer Ingelheim this product will become a game changer in equine health.”

Dr Erich Schoett, of Boehringer, added: “We are proud to continue to set new standards of care for horses to optimise their health and well-being in partnership with veterinarians. Early disease detection and early treatment are key to ensure that horses are healthy and live longer, happier lives.”

Become a member or log in to add this story to your CPD history

Dogs Trust announces winners of vet student awards

News Story 1
 Cambridge vet student James Jewkes has been awarded first place in the annual Dogs Trust EMS Awards, for his paper on the threat of exotic infectious diseases in rehoming centres. James will now go on a two-week placement at the WVS International Training Centre in South India.

Each year the awards allow vet students to gain hands-on experience during work placements at 13 of the charity’s rehoming centres, then submit reports on a relevant subject.  

Click here for more...
News Shorts
Former RCVS president to chair new Horse Welfare Board

Former RCVS president Barry Johnson has been appointed as the independent chair of a new Horse Welfare Board. Barry, who is also past chairman of World Horse Welfare, was selected by an industry panel including the British Horseracing Authority, the Racecourse Association and The Horsemen’s Group.

The welfare board aims to develop a new welfare strategy covering the whole racing industry. Mr Johnson said: “I’m very pleased to have been asked by racing to take on this role and by the sport’s commitment to continuous improvement in the welfare of racehorses."